OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
Símbolo de cotizaciónOSUR
Nombre de la empresaOraSure Technologies Inc
Fecha de salida a bolsaNov 17, 1986
Director ejecutivoMs. Carrie Eglinton Manner
Número de empleados501
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 17
Dirección220 E First St
CiudadBETHLEHEM
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal18015
Teléfono15036416115
Sitio Webhttps://www.orasure.com/
Símbolo de cotizaciónOSUR
Fecha de salida a bolsaNov 17, 1986
Director ejecutivoMs. Carrie Eglinton Manner
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos